Cargando…
Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads
[Image: see text] Six flavonoids present in Pulicaria jaubertii, i.e., 7,3′-di-O-methyltaxifolin (1), 3′-O-methyltaxifolin (2), 7-O-methyltaxifolin (3), taxifolin (4), 3-O-methylquercetin (5), and quercetin (6), were tested for their anticancer activities. The methylated flavonoids, compounds 1–3 an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774329/ https://www.ncbi.nlm.nih.gov/pubmed/36570308 http://dx.doi.org/10.1021/acsomega.2c05565 |
_version_ | 1784855381052227584 |
---|---|
author | Mohammed, Hamdoon A. Almahmoud, Suliman A. El-Ghaly, El-Sayed M. Khan, Firdos Alam Emwas, Abdul-Hamid Jaremko, Mariusz Almulhim, Fatimah Khan, Riaz A. Ragab, Ehab A. |
author_facet | Mohammed, Hamdoon A. Almahmoud, Suliman A. El-Ghaly, El-Sayed M. Khan, Firdos Alam Emwas, Abdul-Hamid Jaremko, Mariusz Almulhim, Fatimah Khan, Riaz A. Ragab, Ehab A. |
author_sort | Mohammed, Hamdoon A. |
collection | PubMed |
description | [Image: see text] Six flavonoids present in Pulicaria jaubertii, i.e., 7,3′-di-O-methyltaxifolin (1), 3′-O-methyltaxifolin (2), 7-O-methyltaxifolin (3), taxifolin (4), 3-O-methylquercetin (5), and quercetin (6), were tested for their anticancer activities. The methylated flavonoids, compounds 1–3 and 5, were evaluated for their anticancer activities in comparison to the non-methylated parent flavonoids taxifolin (4) and quercetin (6). The structures of the known compounds were reconfirmed by spectral analyses using (1)H and (13)C NMR data comparisons and HRMS spectrometry. The anticancer activity of these compounds was evaluated in colon cancer, HCT-116, and noncancerous, HEK-293, cell lines using the MTT antiproliferative assays. The caspase-3 and caspase-9 expressions and DAPI (4′, 6-diamidino-2-phenylindole) staining assays were used to evaluate the apoptotic activity. All the compounds exhibited antiproliferative activity against the HCT-116 cell line with IC(50) values at 33 ± 1.25, 36 ± 2.25, 34 ± 2.15, 32 ± 2.35, 34 ± 2.65, and 36 ± 1.95 μg/mL for compounds 1 to 6, respectively. All the compounds produced a significant reduction in HCT-116 cell line proliferation, except compounds 2 and 6. The viability of the HEK-293 normal cells was found to be significantly higher than the viability of the cancerous cells at all of the tested concentrations, thus suggesting that all the compounds have better inhibitory activity on the cancer cell line. Apoptotic features such as chromatin condensation and nuclear shrinkage were also induced by the compounds. The expression of caspase-3 and caspase-9 genes increased in HCT-116 cell lines after 48 h of treatment, suggesting cell death by the apoptotic pathways. The molecular docking studies showed favorable binding affinity against different pro- and antiapoptotic proteins by these compounds. The docking scores were minimum as compared to the caspase-9, caspase-3, Bcl-xl, and JAK2. |
format | Online Article Text |
id | pubmed-9774329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-97743292022-12-23 Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads Mohammed, Hamdoon A. Almahmoud, Suliman A. El-Ghaly, El-Sayed M. Khan, Firdos Alam Emwas, Abdul-Hamid Jaremko, Mariusz Almulhim, Fatimah Khan, Riaz A. Ragab, Ehab A. ACS Omega [Image: see text] Six flavonoids present in Pulicaria jaubertii, i.e., 7,3′-di-O-methyltaxifolin (1), 3′-O-methyltaxifolin (2), 7-O-methyltaxifolin (3), taxifolin (4), 3-O-methylquercetin (5), and quercetin (6), were tested for their anticancer activities. The methylated flavonoids, compounds 1–3 and 5, were evaluated for their anticancer activities in comparison to the non-methylated parent flavonoids taxifolin (4) and quercetin (6). The structures of the known compounds were reconfirmed by spectral analyses using (1)H and (13)C NMR data comparisons and HRMS spectrometry. The anticancer activity of these compounds was evaluated in colon cancer, HCT-116, and noncancerous, HEK-293, cell lines using the MTT antiproliferative assays. The caspase-3 and caspase-9 expressions and DAPI (4′, 6-diamidino-2-phenylindole) staining assays were used to evaluate the apoptotic activity. All the compounds exhibited antiproliferative activity against the HCT-116 cell line with IC(50) values at 33 ± 1.25, 36 ± 2.25, 34 ± 2.15, 32 ± 2.35, 34 ± 2.65, and 36 ± 1.95 μg/mL for compounds 1 to 6, respectively. All the compounds produced a significant reduction in HCT-116 cell line proliferation, except compounds 2 and 6. The viability of the HEK-293 normal cells was found to be significantly higher than the viability of the cancerous cells at all of the tested concentrations, thus suggesting that all the compounds have better inhibitory activity on the cancer cell line. Apoptotic features such as chromatin condensation and nuclear shrinkage were also induced by the compounds. The expression of caspase-3 and caspase-9 genes increased in HCT-116 cell lines after 48 h of treatment, suggesting cell death by the apoptotic pathways. The molecular docking studies showed favorable binding affinity against different pro- and antiapoptotic proteins by these compounds. The docking scores were minimum as compared to the caspase-9, caspase-3, Bcl-xl, and JAK2. American Chemical Society 2022-12-07 /pmc/articles/PMC9774329/ /pubmed/36570308 http://dx.doi.org/10.1021/acsomega.2c05565 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Mohammed, Hamdoon A. Almahmoud, Suliman A. El-Ghaly, El-Sayed M. Khan, Firdos Alam Emwas, Abdul-Hamid Jaremko, Mariusz Almulhim, Fatimah Khan, Riaz A. Ragab, Ehab A. Comparative Anticancer Potentials of Taxifolin and Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects of O-Methylation on Taxifolin and Quercetin as Preliminary Natural Leads |
title | Comparative Anticancer
Potentials of Taxifolin and
Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects
of O-Methylation on Taxifolin and Quercetin
as Preliminary Natural Leads |
title_full | Comparative Anticancer
Potentials of Taxifolin and
Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects
of O-Methylation on Taxifolin and Quercetin
as Preliminary Natural Leads |
title_fullStr | Comparative Anticancer
Potentials of Taxifolin and
Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects
of O-Methylation on Taxifolin and Quercetin
as Preliminary Natural Leads |
title_full_unstemmed | Comparative Anticancer
Potentials of Taxifolin and
Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects
of O-Methylation on Taxifolin and Quercetin
as Preliminary Natural Leads |
title_short | Comparative Anticancer
Potentials of Taxifolin and
Quercetin Methylated Derivatives against HCT-116 Cell Lines: Effects
of O-Methylation on Taxifolin and Quercetin
as Preliminary Natural Leads |
title_sort | comparative anticancer
potentials of taxifolin and
quercetin methylated derivatives against hct-116 cell lines: effects
of o-methylation on taxifolin and quercetin
as preliminary natural leads |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774329/ https://www.ncbi.nlm.nih.gov/pubmed/36570308 http://dx.doi.org/10.1021/acsomega.2c05565 |
work_keys_str_mv | AT mohammedhamdoona comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT almahmoudsulimana comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT elghalyelsayedm comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT khanfirdosalam comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT emwasabdulhamid comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT jaremkomariusz comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT almulhimfatimah comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT khanriaza comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads AT ragabehaba comparativeanticancerpotentialsoftaxifolinandquercetinmethylatedderivativesagainsthct116celllineseffectsofomethylationontaxifolinandquercetinaspreliminarynaturalleads |